ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 31 filers reported holding ETON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,170 | +19.5% | 1,000 | 0.0% | 0.00% | – |
| Q2 2023 | $3,490 | -9.4% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $3,850 | +36.5% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $2,820 | +41.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $4,000 | -20.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $6,000 | -14.3% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $7,000 | -12.5% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | -27.3% | 1,000 | -50.0% | 0.00% | -50.0% |
| Q2 2020 | $11,000 | +175.0% | 2,000 | +100.0% | 0.00% | +100.0% |
| Q1 2020 | $4,000 | -71.4% | 1,000 | -50.0% | 0.00% | -60.0% |
| Q4 2019 | $14,000 | – | 2,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,430,270 | $10,134,226 | 3.30% |
| Westside Investment Management, Inc. | 528,310 | $2,203,060 | 0.63% |
| Acuitas Investments, LLC | 219,000 | $913,230 | 0.54% |
| EAM Investors, LLC | 256,623 | $1,070,118 | 0.21% |
| Parkman Healthcare Partners LLC | 165,000 | $688,050 | 0.13% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 110,016 | $458,767 | 0.08% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 300,000 | $1,251,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 271,462 | $1,131,997 | 0.03% |
| Quantum Private Wealth, LLC | 11,500 | $47,955 | 0.02% |
| CHICAGO TRUST Co NA | 16,700 | $69,639 | 0.02% |